Schedule 13D ownership disclosure

Savara Inc

Common Stock, par value $0.001 per share · CUSIP: 805111101

Event date: 2025-03-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Bain Capital Life Sciences Fund II, L.P.Reported CIK 0001773187

    Shares: 17,600,621 · Class: 9.99%

  • BCIP Life Sciences Associates, LPReported CIK 0001702921

    Shares: 17,600,621 · Class: 9.99%

  • BCLS II Investco, LPReported CIK 0001818893

    Shares: 17,600,621 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-046213
Form type
SCHEDULE 13D/A
Filer
Bain Capital Life Sciences Fund II, L.P.
CIK
CIK 1773187
Filed
Mar 27, 2025
Reporting period
Mar 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub